| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | TPR GATAD2A ZNF174 HIPK1 MAGEF1 ZNF469 TCERG1 KDM2B KLF17 NOTCH3 NCOA2 FOXO1 XBP1 JPH2 RELA ATF2 CREBBP DICER1 NR2F2 LDB2 ZNF8 NCOR1 OTP TAF3 ATF7IP CNOT1 | 1.50e-05 | 1053 | 203 | 26 | GO:0000122 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | TPR GATAD2A ATRX PHF8 INO80D EMSY PHF2 KMT2C TONSL KDM2B TAF1L RHNO1 BAZ2B CECR2 CHD9 RELA ATF2 CREBBP DICER1 SIRT5 MED15 NCOR1 TAF3 ATF7IP PWWP3A | 1.77e-05 | 999 | 203 | 25 | GO:0071824 |
| GeneOntologyBiologicalProcess | chromatin organization | TPR GATAD2A ATRX PHF8 INO80D EMSY PHF2 KMT2C TONSL KDM2B TAF1L RHNO1 BAZ2B CECR2 CHD9 RELA ATF2 CREBBP DICER1 SIRT5 NCOR1 ATF7IP PWWP3A | 2.65e-05 | 896 | 203 | 23 | GO:0006325 |
| GeneOntologyBiologicalProcess | tube morphogenesis | ERBB2 GATAD2A BCAS3 HIPK1 PAK4 WNK1 ADD1 PGR STIM1 ESRP2 NRXN3 KDM2B STRA6 NOTCH3 TBXA2R HSPG2 FLNA CECR2 EPB41L5 XBP1 RELA ATF2 DICER1 NR2F2 ADAMTS12 DCHS1 | 4.59e-05 | 1125 | 203 | 26 | GO:0035239 |
| GeneOntologyBiologicalProcess | regulation of heterochromatin formation | 8.29e-05 | 24 | 203 | 4 | GO:0031445 | |
| GeneOntologyBiologicalProcess | negative regulation of rDNA heterochromatin formation | 9.64e-05 | 2 | 203 | 2 | GO:0061188 | |
| GeneOntologyBiologicalProcess | positive regulation of adherens junction organization | 9.64e-05 | 2 | 203 | 2 | GO:1903393 | |
| GeneOntologyBiologicalProcess | protein demethylation | 1.07e-04 | 10 | 203 | 3 | GO:0006482 | |
| GeneOntologyBiologicalProcess | protein dealkylation | 1.07e-04 | 10 | 203 | 3 | GO:0008214 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | TPR GATAD2A ZNF174 HIPK1 ZNF318 MAGEF1 TRIM66 ZNF469 TCERG1 KDM2B KLF17 NOTCH3 NCOA2 FOXO1 FLNA XBP1 JPH2 RELA ATF2 CREBBP DICER1 NR2F2 LDB2 ZNF8 NCOR1 OTP TAF3 ATF7IP CNOT1 | 1.13e-04 | 1399 | 203 | 29 | GO:0045892 |
| GeneOntologyBiologicalProcess | tube development | ERBB2 GATAD2A ATRX BCAS3 HIPK1 PAK4 WNK1 ADD1 PGR STIM1 ESRP2 NRXN3 KDM2B STRA6 NOTCH3 TBXA2R HSPG2 FLNA CECR2 EPB41L5 XBP1 RELA ATF2 DICER1 NR2F2 ADAMTS12 DCHS1 ROBO2 INKA1 | 1.17e-04 | 1402 | 203 | 29 | GO:0035295 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | TPR GATAD2A ZNF174 HIPK1 ZNF318 MAGEF1 TRIM66 ZNF469 TCERG1 KDM2B KLF17 NOTCH3 NCOA2 FOXO1 FLNA XBP1 JPH2 RELA ATF2 CREBBP DICER1 NR2F2 LDB2 ZNF8 NCOR1 OTP TAF3 ATF7IP CNOT1 | 1.34e-04 | 1413 | 203 | 29 | GO:1902679 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | TPR BCL9L GATAD2A TFDP3 GPKOW INO80D KMT2C TONSL CLTC KDM2B RBM47 TAF1L MVP PLRG1 CSTF2T NCOA2 FLNA CECR2 POLR2A XBP1 RELA ATF2 CREBBP MED15 NCOR1 TAF3 ASXL3 PABPC3 CSTF2 | 6.79e-05 | 1377 | 203 | 29 | GO:0140513 |
| Domain | ZF_PHD_2 | 6.60e-08 | 95 | 198 | 10 | PS50016 | |
| Domain | ZF_PHD_1 | 7.30e-08 | 96 | 198 | 10 | PS01359 | |
| Domain | PHD | 4.69e-06 | 89 | 198 | 8 | SM00249 | |
| Domain | Znf_PHD | 5.55e-06 | 91 | 198 | 8 | IPR001965 | |
| Domain | Znf_PHD-finger | 2.06e-05 | 79 | 198 | 7 | IPR019787 | |
| Domain | ZnF_C2HC | 2.48e-05 | 55 | 198 | 6 | SM00343 | |
| Domain | Znf_CCHC | 2.48e-05 | 55 | 198 | 6 | IPR001878 | |
| Domain | Znf_FYVE_PHD | 2.75e-05 | 147 | 198 | 9 | IPR011011 | |
| Domain | BROMODOMAIN_1 | 4.21e-05 | 37 | 198 | 5 | PS00633 | |
| Domain | Bromodomain | 4.81e-05 | 38 | 198 | 5 | PF00439 | |
| Domain | CH | 6.46e-05 | 65 | 198 | 6 | SM00033 | |
| Domain | BROMODOMAIN_2 | 7.00e-05 | 41 | 198 | 5 | PS50014 | |
| Domain | Bromodomain | 7.87e-05 | 42 | 198 | 5 | IPR001487 | |
| Domain | BROMO | 7.87e-05 | 42 | 198 | 5 | SM00297 | |
| Domain | - | 7.87e-05 | 42 | 198 | 5 | 1.20.920.10 | |
| Domain | CH | 9.82e-05 | 70 | 198 | 6 | PF00307 | |
| Domain | - | 1.06e-04 | 71 | 198 | 6 | 1.10.418.10 | |
| Domain | CSTF2_hinge | 1.12e-04 | 2 | 198 | 2 | PF14327 | |
| Domain | CSTF_C | 1.12e-04 | 2 | 198 | 2 | PF14304 | |
| Domain | CSTF2_hinge | 1.12e-04 | 2 | 198 | 2 | IPR025742 | |
| Domain | CSTF_C | 1.12e-04 | 2 | 198 | 2 | IPR026896 | |
| Domain | CH | 1.24e-04 | 73 | 198 | 6 | PS50021 | |
| Domain | PHD | 1.44e-04 | 75 | 198 | 6 | PF00628 | |
| Domain | CH-domain | 1.44e-04 | 75 | 198 | 6 | IPR001715 | |
| Domain | Bromodomain_CS | 1.53e-04 | 26 | 198 | 4 | IPR018359 | |
| Domain | PUB | 3.33e-04 | 3 | 198 | 2 | PF09409 | |
| Domain | CNH | 3.92e-04 | 14 | 198 | 3 | SM00036 | |
| Domain | CNH | 4.86e-04 | 15 | 198 | 3 | PF00780 | |
| Domain | CNH | 4.86e-04 | 15 | 198 | 3 | PS50219 | |
| Domain | CNH_dom | 4.86e-04 | 15 | 198 | 3 | IPR001180 | |
| Domain | Ig_I-set | 9.72e-04 | 190 | 198 | 8 | IPR013098 | |
| Domain | I-set | 9.72e-04 | 190 | 198 | 8 | PF07679 | |
| Domain | PolyA | 1.09e-03 | 5 | 198 | 2 | SM00517 | |
| Domain | Anaphylatoxin_comp_syst | 1.09e-03 | 5 | 198 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 1.09e-03 | 5 | 198 | 2 | IPR001840 | |
| Domain | - | 1.09e-03 | 5 | 198 | 2 | 1.10.1900.10 | |
| Domain | PABP | 1.09e-03 | 5 | 198 | 2 | PF00658 | |
| Domain | PABP_1234 | 1.09e-03 | 5 | 198 | 2 | IPR006515 | |
| Domain | PABC | 1.09e-03 | 5 | 198 | 2 | PS51309 | |
| Domain | PABP_HYD | 1.09e-03 | 5 | 198 | 2 | IPR002004 | |
| Domain | Nuc_rcpt_coact | 1.63e-03 | 6 | 198 | 2 | IPR009110 | |
| Domain | PUB_domain | 1.63e-03 | 6 | 198 | 2 | IPR018997 | |
| Pathway | REACTOME_ADIPOGENESIS | 1.35e-05 | 110 | 140 | 8 | M48259 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS | 1.67e-05 | 55 | 140 | 6 | M27145 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | 1.96e-05 | 84 | 140 | 7 | M1008 | |
| Pathway | WP_ANDROGEN_RECEPTOR_SIGNALING | 3.31e-05 | 91 | 140 | 7 | M39700 | |
| Pathway | BIOCARTA_PCAF_PATHWAY | 7.71e-05 | 9 | 140 | 3 | MM1533 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | GATAD2A PHF8 PHF2 KMT2C KDM2B NCOA2 RELA ATF2 CREBBP NCOR1 ATF7IP | 8.48e-05 | 272 | 140 | 11 | M29619 |
| Pathway | REACTOME_HEME_SIGNALING | 1.21e-04 | 49 | 140 | 5 | M41832 | |
| Pathway | PID_SMAD2_3NUCLEAR_PATHWAY | 1.62e-04 | 82 | 140 | 6 | M2 | |
| Pathway | BIOCARTA_PCAF_PATHWAY | 2.55e-04 | 13 | 140 | 3 | M22007 | |
| Pubmed | FAM90A14 FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 1.24e-18 | 25 | 210 | 11 | 17684299 | |
| Pubmed | FAM90A14 FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A7 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 5.55e-17 | 23 | 210 | 10 | 18602769 | |
| Pubmed | TPR ATXN2L SPTBN2 ZNF318 PHF8 EMSY ADD1 KMT2C TCERG1 CLTC KDM2B CSTF2T PRRC2B NCOA2 FLNA DSG2 POLR2A PTPN23 CREBBP MED15 NCOR1 TAF3 CSTF2 PEAK1 CNOT1 | 5.81e-15 | 549 | 210 | 25 | 38280479 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TPR ATXN2L PDE4C ATRX UBE4B ZNF318 PHF8 EMSY USP19 ADD1 USP42 EIF2B5 CLTC KDM2B CSTF2T FLNA EML4 POLR2A YTHDC2 IQCN ATF2 MICALL1 NCOR1 TAF3 MAP4K1 ESPL1 CXADR | 2.66e-13 | 774 | 210 | 27 | 15302935 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | ATXN2L ATRX HIPK1 ZNF318 WNK1 EMSY TCERG1 TONSL CLTC KDM2B PLRG1 PRRC2B NCOA2 FOXO1 CREBBP ZC3H7A NCOR1 ATF7IP CRYBG3 GARRE1 | 6.05e-10 | 588 | 210 | 20 | 38580884 |
| Pubmed | TPR HIPK1 SPTBN2 PAK4 WNK1 KMT2C TCERG1 CLTC NAV2 C4A FLNA CDC42BPA PTPN23 RELA CREBBP ZC3H7A USF3 ATF7IP | 1.20e-09 | 486 | 210 | 18 | 20936779 | |
| Pubmed | BCL9L GATAD2A ATRX PABPC4 SSBP2 ZNF318 GIGYF1 PHF8 INO80D EMSY PHF2 RNF214 KMT2C TCERG1 KDM2B TAF1L PRRC2B NCOA2 HSPG2 CDC42BPA RELA CREBBP MED15 NCOR1 TAF3 ATF7IP PABPC3 CSTF2 CNOT1 GARRE1 | 3.03e-09 | 1429 | 210 | 30 | 35140242 | |
| Pubmed | GALNT2 ATRX GIGYF1 TCERG1 TONSL EIF2B5 SIK2 C4A C4B TMEM223 RBM47 PLRG1 PRRC2B RNF31 EML4 YTHDC2 ANKZF1 DICER1 CRYBG3 GARRE1 | 3.34e-09 | 650 | 210 | 20 | 38777146 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | TPR ATXN2L GATAD2A ATRX ZNF174 PABPC4 ZNF318 GPKOW EMSY PHF2 PRAM1 TCERG1 CLTC TAF1L PLRG1 FLNA BAZ2B EML4 POLR2A NCOR1 TAF3 ATF7IP PABPC3 CSTF2 | 4.40e-09 | 954 | 210 | 24 | 36373674 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ATXN2L ERBB2 BCAS3 PAK4 GIGYF1 WNK1 STIM1 TCERG1 SIK2 NAV2 FOXO1 CDC42BPA DSG2 EPB41L5 SPECC1 CARD8 MICALL1 USP8 MAP4K1 CRYBG3 PEAK1 GARRE1 | 1.54e-08 | 861 | 210 | 22 | 36931259 |
| Pubmed | ATXN2L GATAD2A ZNF174 PABPC4 ZNF318 INO80D EMSY PHF2 PRAM1 KMT2C TCERG1 CLTC PLRG1 CSTF2T PRRC2B NCOA2 FLNA BAZ2B CAMK2G CHD9 ATF2 CREBBP MED15 NCOR1 CNOT1 | 1.61e-08 | 1103 | 210 | 25 | 34189442 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | ATXN2L BCAS3 PABPC4 PAK4 ADD1 STIM1 RNF214 LPCAT2 PLRG1 PRRC2B FLNA EML4 CAMK2G EPB41L5 YTHDC2 DICER1 MICALL1 ZC3H7A ESPL1 CNOT1 | 2.02e-08 | 724 | 210 | 20 | 36232890 |
| Pubmed | Placental PPARγ regulates spatiotemporally diverse genes and a unique metabolic network. | FAM90A14 FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A7 FAM90A9 FAM90A8 FAM90A10 INKA1 | 6.79e-08 | 164 | 210 | 10 | 22967998 |
| Pubmed | ERBB2 GATAD2A ZNF318 GIGYF1 PHF8 INO80D PHF2 TRIM66 ZNF469 PRRC2B RNF31 DSG2 CECR2 POLR2A CHD9 YTHDC2 PPFIA3 CREBBP DICER1 SIRT5 ZNF8 TAF3 CRYBG3 GARRE1 | 8.47e-08 | 1116 | 210 | 24 | 31753913 | |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | TNIK ERBB2 SCARF2 PAK4 INPP4B ADD1 LPCAT2 STRA6 CDC42BPA DSG2 EPB41L5 MICALL1 PEAK1 CXADR | 8.55e-08 | 377 | 210 | 14 | 38117590 |
| Pubmed | TNIK PHF8 WNK1 PHF2 KMT2C SIK2 NAV2 PTPN23 PPFIA3 DICER1 DIP2C | 1.42e-07 | 225 | 210 | 11 | 12168954 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TNIK TPR ATXN2L ATRX PAK4 ZNF318 WNK1 GPKOW EMSY ADD1 TCERG1 PLRG1 PRRC2B FLNA PSAT1 DSG2 POLR2A PTPN23 YTHDC2 USP8 ATF7IP | 2.79e-07 | 934 | 210 | 21 | 33916271 |
| Pubmed | ZNF174 TFDP3 ZNF318 PGR KMT2C KLF17 SERTAD1 NCOA2 FOXO1 RNF31 XBP1 ATF2 CREBBP NR2F2 LDB2 OTP MTF1 FBLIM1 | 3.66e-07 | 709 | 210 | 18 | 22988430 | |
| Pubmed | DUSP28 ZNF174 SPTBN2 PAK4 PHF8 STIM1 PHF2 PMPCA CLTC PRRC2B PSAT1 CDC42BPA POLR2A PTPN23 RELA PPFIA3 NCOR1 CSTF2 CRYBG3 PEAK1 CNOT1 CXADR | 4.63e-07 | 1049 | 210 | 22 | 27880917 | |
| Pubmed | 8.64e-07 | 4 | 210 | 3 | 15735738 | ||
| Pubmed | ERBB2 PAK4 KMT2C NRXN3 NAV2 KDM2B SDK2 CDC42BPA CECR2 DICER1 MICALL1 ROBO2 ESPL1 CNOT1 GARRE1 | 9.18e-07 | 529 | 210 | 15 | 14621295 | |
| Pubmed | SCARF2 PABPC4 ZNF318 USP19 ADD1 STIM1 CLTC SDK1 PRRC2B CDC42BPA DSG2 EPB41L5 RELA NCOR1 ATF7IP PWWP3A PEAK1 CXADR | 1.35e-06 | 777 | 210 | 18 | 35844135 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | TNIK BCAS3 PABPC4 PAK4 GIGYF1 WNK1 GPKOW ADD1 EIF2B5 SIK2 PLRG1 PSRC1 FOXO1 POLR2A RELA MSH5 ANKZF1 ZC3H7A FBLIM1 ESPL1 CNOT1 | 1.51e-06 | 1038 | 210 | 21 | 26673895 |
| Pubmed | TPR ATXN2L ERBB2 PABPC4 PAK4 ADD1 STIM1 TCERG1 CDC42BPA DSG2 EPB41L5 PTPN23 YTHDC2 MICALL1 CRYBG3 PEAK1 CNOT1 | 1.66e-06 | 708 | 210 | 17 | 39231216 | |
| Pubmed | BCAS3 HIPK1 KMT2C NYNRIN NCOA2 PCDH11Y YTHDC2 ANKZF1 NCOR1 PDE4DIP | 1.73e-06 | 233 | 210 | 10 | 37704626 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | BCL9L SSBP2 EMSY KMT2C KDM2B PRRC2B NCOA2 CREBBP MED15 NCOR1 TAF3 ASXL3 | 1.73e-06 | 351 | 210 | 12 | 38297188 |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | ATXN2L ERBB2 SPTBN2 PAK4 ADD1 STIM1 NAV2 NOTCH3 FLNA DSG2 SPECC1 MICALL1 USP8 PEAK1 CXADR | 2.06e-06 | 565 | 210 | 15 | 25468996 |
| Pubmed | CBP Is a dosage-dependent regulator of nuclear factor-kappaB suppression by the estrogen receptor. | 2.15e-06 | 5 | 210 | 3 | 17932106 | |
| Pubmed | 2.15e-06 | 5 | 210 | 3 | 9659924 | ||
| Pubmed | 2.15e-06 | 5 | 210 | 3 | 17296604 | ||
| Pubmed | 3.27e-06 | 38 | 210 | 5 | 28680062 | ||
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 4.41e-06 | 203 | 210 | 9 | 22083510 | |
| Pubmed | 4.66e-06 | 71 | 210 | 6 | 12754519 | ||
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | TPR BCL9L GIGYF1 GPKOW KMT2C STRA6 RBM47 PRRC2B NCOA2 CREBBP MED15 NCOR1 CNOT1 | 4.80e-06 | 457 | 210 | 13 | 32344865 |
| Pubmed | ATXN2L GIGYF1 WNK1 NYNRIN CSTF2T PRRC2B SERTAD1 HSPG2 RNF31 MED15 NCOR1 PDE4DIP CSTF2 ROBO2 DMRTB1 | 5.01e-06 | 608 | 210 | 15 | 16713569 | |
| Pubmed | ERBB2 ZNF318 GIGYF1 STIM1 XYLT2 KMT2C USP42 EIF2B5 TAF1L PRRC2B DSG2 XBP1 NCOR1 PDE4DIP ROBO2 NEIL3 | 5.17e-06 | 689 | 210 | 16 | 36543142 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | TPR GATAD2A BCAS3 HIPK1 EMSY ESRP2 TCERG1 NOTCH3 NCOA2 FOXO1 POLR2A RELA ATF2 CREBBP NR2F2 DARS2 LDB2 NCOR1 | 5.27e-06 | 857 | 210 | 18 | 25609649 |
| Pubmed | 5.98e-06 | 268 | 210 | 10 | 33640491 | ||
| Pubmed | TPR ATXN2L DUSP28 ATRX UBE4B TSC22D2 HSD11B1L WNK1 INO80D EMSY USP19 XYLT2 RNF214 KMT2C CLTC STRA6 FLNA CAMK2G DICER1 ZC3H7A TAF3 MTF1 CNOT1 | 6.19e-06 | 1327 | 210 | 23 | 32694731 | |
| Pubmed | 6.42e-06 | 75 | 210 | 6 | 25593309 | ||
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | ZNF174 SSBP2 PHF2 TONSL KDM2B PLRG1 SERTAD1 NCOA2 POLR2A XBP1 RELA ANKZF1 ATF2 CREBBP NR2F2 LDB2 MTF1 DIP2C | 7.22e-06 | 877 | 210 | 18 | 20211142 |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | ATXN2L GATAD2A UBE4B SPTBN2 PABPC4 CLTC C4A C4B FLNA PSAT1 DSG2 PPFIA3 SPECC1 | 7.60e-06 | 477 | 210 | 13 | 31300519 |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | ATXN2L UBE4B PHF8 EMSY EIF2B5 PLRG1 POLR2A DARS2 NCOR1 YIF1B PPT1 | 8.15e-06 | 341 | 210 | 11 | 32971831 |
| Pubmed | GATAD2A GPKOW KDM2B PRRC2B ACSS3 NCOA2 CAMK2G PPFIA3 CREBBP MED15 NCOR1 USP8 PPT1 ASXL3 CNOT1 | 8.88e-06 | 638 | 210 | 15 | 31182584 | |
| Pubmed | Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. | GATAD2A PHF2 TRIM66 RNF214 TMEM132A EIF2B5 POLR2A RELA MED15 FBLIM1 | 9.63e-06 | 283 | 210 | 10 | 18854154 |
| Pubmed | TPR TFDP3 ZNF318 KDM2B CSTF2T FLNA CAMK2G ZNF8 NCOR1 ATF7IP CRYBG3 CNOT1 | 1.02e-05 | 418 | 210 | 12 | 34709266 | |
| Pubmed | TNIK ATXN2L GATAD2A SPTBN2 PABPC4 GPKOW ADD1 PHF2 TCERG1 CLTC C4B RBM47 PLRG1 PRRC2B FLNA CDC42BPA DSG2 EML4 EPB41L5 ANKZF1 DICER1 TAF3 CNOT1 | 1.05e-05 | 1371 | 210 | 23 | 36244648 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | TNIK SCARF2 SPTBN2 PAK4 NAV2 CDC42BPA DSG2 UBXN6 EPB41L5 JPH2 SPECC1 MICALL1 PEAK1 CXADR | 1.07e-05 | 569 | 210 | 14 | 30639242 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | SPTBN2 C11orf24 PHF8 ESRP2 KMT2C ADRA1D CLTC TICRR BAZ2B POLR2A BRME1 IGDCC3 PPFIA3 DARS2 CSTF2 CNOT1 | 1.17e-05 | 736 | 210 | 16 | 29676528 |
| Pubmed | 1.19e-05 | 8 | 210 | 3 | 14670299 | ||
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 1.25e-05 | 231 | 210 | 9 | 16452087 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ERBB2 UBE4B BCAS3 WNK1 CHRM4 ESRP2 KMT2C TMEM132A NAV2 TP53I13 PRRC2B HSPG2 FLNA CDC42BPA POLR2A NR2F2 MICALL1 NCOR1 DIP2C ESPL1 | 1.39e-05 | 1105 | 210 | 20 | 35748872 |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 1.49e-05 | 180 | 210 | 8 | 35198878 | |
| Pubmed | 1.80e-05 | 242 | 210 | 9 | 34011540 | ||
| Pubmed | GALNT2 PHF8 C4A SDK1 NCOA2 RNF31 POLR2A EPB41L5 ANKZF1 ATF2 CREBBP PPT1 CNOT1 | 2.44e-05 | 533 | 210 | 13 | 25544563 | |
| Pubmed | 2.48e-05 | 57 | 210 | 5 | 18022353 | ||
| Pubmed | TNIK TPR SPTBN2 ZNF318 EMSY ADD1 CLTC PRRC2B NCOA2 CAMK2G PPFIA3 LDB2 NCOR1 ATF7IP PABPC3 PDE4DIP DCHS1 CNOT1 | 2.51e-05 | 963 | 210 | 18 | 28671696 | |
| Pubmed | Combination of factor H mutation and properdin deficiency causes severe C3 glomerulonephritis. | 3.46e-05 | 11 | 210 | 3 | 23204401 | |
| Pubmed | ZNF318 GIGYF1 TCERG1 PRRC2B EPB41L5 YTHDC2 CRYBG3 PEAK1 CNOT1 | 3.46e-05 | 263 | 210 | 9 | 34702444 | |
| Pubmed | TPR ATRX PAK4 ZNF318 CAMTA2 WNK1 KMT2C AMMECR1L CLTC NCOA2 FLNA TICRR PTPN23 MSH5 ATF2 CSTF2 PEAK1 ESPL1 CNOT1 | 3.56e-05 | 1084 | 210 | 19 | 11544199 | |
| Pubmed | 3.63e-05 | 2 | 210 | 2 | 23100252 | ||
| Pubmed | 3.63e-05 | 2 | 210 | 2 | 19062096 | ||
| Pubmed | Recognition of GU-rich polyadenylation regulatory elements by human CstF-64 protein. | 3.63e-05 | 2 | 210 | 2 | 12773396 | |
| Pubmed | 3.63e-05 | 2 | 210 | 2 | 9548485 | ||
| Pubmed | 3.63e-05 | 2 | 210 | 2 | 37962238 | ||
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 3.63e-05 | 2 | 210 | 2 | 17645767 | |
| Pubmed | 3.63e-05 | 2 | 210 | 2 | 12207352 | ||
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 3.63e-05 | 2 | 210 | 2 | 27758680 | |
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 3.63e-05 | 2 | 210 | 2 | 3037333 | |
| Pubmed | 3.63e-05 | 2 | 210 | 2 | 11726230 | ||
| Pubmed | 3.63e-05 | 2 | 210 | 2 | 4216347 | ||
| Pubmed | 3.63e-05 | 2 | 210 | 2 | 26579819 | ||
| Pubmed | Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain. | 3.63e-05 | 2 | 210 | 2 | 8428773 | |
| Pubmed | 3.63e-05 | 2 | 210 | 2 | 24638111 | ||
| Pubmed | Transcriptional repression of C4 complement by hepatitis C virus proteins. | 3.63e-05 | 2 | 210 | 2 | 21345967 | |
| Pubmed | 3.63e-05 | 2 | 210 | 2 | 33849822 | ||
| Pubmed | 3.63e-05 | 2 | 210 | 2 | 26577046 | ||
| Pubmed | 3.63e-05 | 2 | 210 | 2 | 2302180 | ||
| Pubmed | 3.63e-05 | 2 | 210 | 2 | 22151770 | ||
| Pubmed | 3.63e-05 | 2 | 210 | 2 | 29080553 | ||
| Pubmed | C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production. | 3.63e-05 | 2 | 210 | 2 | 25339671 | |
| Pubmed | 3.63e-05 | 2 | 210 | 2 | 17728371 | ||
| Pubmed | 3.63e-05 | 2 | 210 | 2 | 6149580 | ||
| Pubmed | 3.63e-05 | 2 | 210 | 2 | 6149581 | ||
| Pubmed | 3.63e-05 | 2 | 210 | 2 | 3542363 | ||
| Pubmed | 3.63e-05 | 2 | 210 | 2 | 18096667 | ||
| Pubmed | 3.63e-05 | 2 | 210 | 2 | 2387317 | ||
| Pubmed | 3.63e-05 | 2 | 210 | 2 | 30150416 | ||
| Pubmed | 3.63e-05 | 2 | 210 | 2 | 7365238 | ||
| Pubmed | 3.63e-05 | 2 | 210 | 2 | 17971360 | ||
| Pubmed | Analysis of C4 and the C4 binding protein in the MRL/lpr mouse. | 3.63e-05 | 2 | 210 | 2 | 17971229 | |
| Pubmed | [Clinicopathological features of young patients with triple negative breast cancer]. | 3.63e-05 | 2 | 210 | 2 | 19838027 | |
| Pubmed | 3.63e-05 | 2 | 210 | 2 | 35898513 | ||
| Pubmed | 3.63e-05 | 2 | 210 | 2 | 28873507 | ||
| Pubmed | 3.63e-05 | 2 | 210 | 2 | 3794341 | ||
| Pubmed | 3.63e-05 | 2 | 210 | 2 | 31923801 | ||
| Pubmed | Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling. | 3.63e-05 | 2 | 210 | 2 | 14576841 | |
| Pubmed | 3.63e-05 | 2 | 210 | 2 | 22785613 | ||
| Pubmed | 3.63e-05 | 2 | 210 | 2 | 32691186 | ||
| Pubmed | The androgen-dependent C4-Slp gene is driven by a constitutively competent promoter. | 3.63e-05 | 2 | 210 | 2 | 8390682 | |
| Interaction | BAG2 interactions | TNIK ZNF318 WNK1 ESRP2 TRIM66 RNF214 CLTC SIK2 CSTF2T NOTCH3 NCOA2 FOXO1 RNF31 EML4 PLEKHA4 PTPN23 RELA CREBBP NR2F2 NCOR1 ESPL1 | 7.11e-07 | 622 | 195 | 21 | int:BAG2 |
| Interaction | UBAP2L interactions | ATXN2L PABPC4 GIGYF1 ESRP2 RNF214 RBM47 PRRC2B FOXO1 PLEKHA4 MED15 ZC3H7A PPT1 CNOT1 GARRE1 | 1.31e-06 | 298 | 195 | 14 | int:UBAP2L |
| Interaction | LYN interactions | TNIK ERBB2 SPTBN2 PAK4 TFDP3 PHF8 ADD1 PHF2 PRAM1 SDK2 CDC42BPA DSG2 PLEKHA4 EPB41L5 SPECC1 CREBBP MICALL1 MAP4K1 DENND2C ROBO2 PEAK1 CXADR | 1.99e-06 | 720 | 195 | 22 | int:LYN |
| Interaction | CTBP2 interactions | TNIK GATAD2A BCAS3 HIPK1 TMC3 KDM2B BAZ2B POLR2A SYT6 PLEKHA4 PTPN23 RELA CREBBP CSTF2 DMRTB1 | 3.39e-06 | 370 | 195 | 15 | int:CTBP2 |
| Interaction | TNRC6A interactions | GATAD2A GIGYF1 WNK1 TRIM66 KMT2C NYNRIN CLTC PRRC2B RNF31 ZC3H7A DMRTB1 CNOT1 GARRE1 | 3.61e-06 | 280 | 195 | 13 | int:TNRC6A |
| Interaction | WWTR1 interactions | ATXN2L ZNF318 EMSY TCERG1 CLTC CSTF2T PRRC2B NCOA2 DSG2 POLR2A PTPN23 CREBBP NCOR1 CSTF2 PEAK1 CNOT1 | 3.74e-06 | 422 | 195 | 16 | int:WWTR1 |
| Interaction | MKRN2 interactions | ERBB2 ATRX PABPC4 RNF214 RBM47 SDK1 PLRG1 NOTCH3 PRRC2B PLEKHA4 RELA ZC3H7A PPT1 CNOT1 GARRE1 | 5.48e-06 | 385 | 195 | 15 | int:MKRN2 |
| Interaction | EGR2 interactions | BCL9L SSBP2 EMSY KMT2C KDM2B PRRC2B NCOA2 CREBBP NCOR1 PDE4DIP | 6.68e-06 | 171 | 195 | 10 | int:EGR2 |
| Interaction | ZC3H7A interactions | ATXN2L PABPC4 GIGYF1 RNF214 NYNRIN RBM47 PRRC2B PLEKHA4 ZC3H7A CNOT1 GARRE1 | 8.28e-06 | 215 | 195 | 11 | int:ZC3H7A |
| Interaction | PRRC2B interactions | TNIK TRIM66 RNF214 RBM47 PRRC2B CECR2 PLEKHA4 YTHDC2 ZC3H7A DMRTB1 CNOT1 GARRE1 | 1.11e-05 | 265 | 195 | 12 | int:PRRC2B |
| Interaction | AR interactions | TPR BCL9L ATRX SSBP2 ZNF318 EMSY KMT2C TONSL CLTC KDM2B PLRG1 PRRC2B NCOA2 FOXO1 FLNA CDC42BPA RNF31 DSG2 UBXN6 RELA ATF2 CREBBP MED15 NCOR1 TNS4 | 1.15e-05 | 992 | 195 | 25 | int:AR |
| Interaction | ERG interactions | HIPK1 EMSY KMT2C CLTC KDM2B PRRC2B NCOA2 POLR2A CREBBP NCOR1 ATF7IP | 1.17e-05 | 223 | 195 | 11 | int:ERG |
| Interaction | SMC5 interactions | TPR ATXN2L GATAD2A ATRX ZNF174 PABPC4 ZNF318 GPKOW EMSY PHF2 PRAM1 TCERG1 CLTC TAF1L PLRG1 FLNA BAZ2B EML4 POLR2A PLEKHA4 NCOR1 TAF3 ATF7IP PABPC3 CSTF2 | 1.32e-05 | 1000 | 195 | 25 | int:SMC5 |
| Interaction | SFN interactions | TNIK ATXN2L PAK4 GIGYF1 WNK1 CLTC SIK2 NAV2 FOXO1 CDC42BPA DSG2 EPB41L5 SPECC1 ATF2 CARD8 USP8 TNS4 CRYBG3 PEAK1 GARRE1 | 1.35e-05 | 692 | 195 | 20 | int:SFN |
| Interaction | SMG7 interactions | ZNF318 TRIM66 RNF214 KDM2B RBM47 PRRC2B NCOA2 PLEKHA4 CREBBP ZC3H7A NCOR1 CNOT1 GARRE1 | 1.47e-05 | 319 | 195 | 13 | int:SMG7 |
| Interaction | IRF3 interactions | 1.50e-05 | 149 | 195 | 9 | int:IRF3 | |
| Interaction | FAM120C interactions | PABPC4 GIGYF1 ESRP2 TRIM66 RNF214 NYNRIN PRRC2B ZC3H7A CNOT1 GARRE1 | 1.76e-05 | 191 | 195 | 10 | int:FAM120C |
| Interaction | CPEB4 interactions | PABPC4 GIGYF1 TRIM66 RBM47 CSTF2T PRRC2B ZC3H7A CNOT1 GARRE1 | 2.17e-05 | 156 | 195 | 9 | int:CPEB4 |
| Interaction | CAMK4 interactions | 2.24e-05 | 59 | 195 | 6 | int:CAMK4 | |
| Interaction | YWHAG interactions | ATXN2L BCAS3 PABPC4 PAK4 GIGYF1 WNK1 STIM1 TCERG1 CLTC SIK2 NAV2 FOXO1 FLNA TICRR CDC42BPA RNF31 DSG2 CAMK2G PLEKHA4 EPB41L5 SPECC1 ATF2 MICALL1 USP8 PPT1 DENND2C PEAK1 GARRE1 | 2.78e-05 | 1248 | 195 | 28 | int:YWHAG |
| Interaction | OCLN interactions | TNIK ERBB2 SPTBN2 PAK4 ADD1 CLTC C4A SDK2 CDC42BPA DSG2 PLEKHA4 EPB41L5 SPECC1 ROBO2 PEAK1 CXADR | 3.06e-05 | 500 | 195 | 16 | int:OCLN |
| Interaction | PAPOLA interactions | 3.12e-05 | 92 | 195 | 7 | int:PAPOLA | |
| Interaction | TRIM66 interactions | ERBB2 ZNF318 GIGYF1 PHF8 TRIM66 PRRC2B DSG2 YTHDC2 CRYBG3 GARRE1 | 3.23e-05 | 205 | 195 | 10 | int:TRIM66 |
| Interaction | FXR1 interactions | TNIK ATXN2L PABPC4 PRAM1 RNF214 MVP PRRC2B SERTAD1 FLNA CAMK2G CECR2 SYT6 PLEKHA4 PPFIA3 SPECC1 ZC3H7A NCOR1 NEIL3 CNOT1 | 3.48e-05 | 679 | 195 | 19 | int:FXR1 |
| Interaction | KCNA3 interactions | TPR ATXN2L ERBB2 PABPC4 PAK4 ADD1 STIM1 KMT2C TCERG1 NCOA2 CACNA1B CDC42BPA DSG2 EPB41L5 PTPN23 CHD9 YTHDC2 SPECC1 MICALL1 CRYBG3 PEAK1 CNOT1 | 3.89e-05 | 871 | 195 | 22 | int:KCNA3 |
| Interaction | HELZ interactions | PABPC4 RNF214 CLTC RBM47 PRRC2B UBXN6 PLEKHA4 CREBBP ZC3H7A CNOT1 GARRE1 | 4.33e-05 | 257 | 195 | 11 | int:HELZ |
| Interaction | YWHAB interactions | ATXN2L PABPC4 PAK4 GIGYF1 WNK1 STIM1 CLTC SIK2 NAV2 FOXO1 TICRR CDC42BPA DSG2 CAMK2G PLEKHA4 EPB41L5 SPECC1 ATF2 MICALL1 USP8 PPT1 DENND2C PEAK1 GARRE1 | 4.78e-05 | 1014 | 195 | 24 | int:YWHAB |
| Interaction | MCAM interactions | TNIK ERBB2 SCARF2 PAK4 INPP4B ADD1 LPCAT2 STRA6 CDC42BPA DSG2 EPB41L5 MICALL1 ATF7IP PEAK1 CXADR | 5.35e-05 | 468 | 195 | 15 | int:MCAM |
| Interaction | YTHDF2 interactions | ATXN2L PABPC4 GIGYF1 RNF214 RBM47 PRRC2B PLEKHA4 PTPN23 CREBBP ZC3H7A CNOT1 GARRE1 | 5.51e-05 | 312 | 195 | 12 | int:YTHDF2 |
| Interaction | POU5F1 interactions | TPR GATAD2A ZNF157 PAK4 EMSY PRAM1 TCERG1 USP42 KDM2B PRRC2B HSPG2 FLNA XBP1 SPECC1 ATF2 NR2F2 CNOT1 | 5.63e-05 | 584 | 195 | 17 | int:POU5F1 |
| Interaction | YWHAH interactions | ATXN2L BCAS3 PAK4 GIGYF1 WNK1 STIM1 TCERG1 SIK2 NAV2 NCOA2 FOXO1 TICRR CDC42BPA DSG2 CAMK2G PLEKHA4 EPB41L5 SPECC1 CREBBP MICALL1 USP8 DENND2C CRYBG3 PEAK1 GARRE1 | 6.53e-05 | 1102 | 195 | 25 | int:YWHAH |
| Interaction | FMR1 interactions | TNIK ATXN2L EMSY RNF214 MVP PLRG1 PRRC2B NCOA2 CAMK2G CECR2 PLEKHA4 FSD2 LDB2 ZC3H7A NCOR1 CNOT1 | 6.98e-05 | 536 | 195 | 16 | int:FMR1 |
| Interaction | ZSCAN18 interactions | 7.19e-05 | 45 | 195 | 5 | int:ZSCAN18 | |
| Interaction | ALG13 interactions | 7.55e-05 | 183 | 195 | 9 | int:ALG13 | |
| Interaction | HNF4A interactions | ATRX PABPC4 EMSY KMT2C KDM2B NCOA2 FOXO1 CREBBP NCOR1 TAF3 ATF7IP | 7.96e-05 | 275 | 195 | 11 | int:HNF4A |
| Interaction | FXR2 interactions | TNIK IGFN1 PRAM1 RNF214 MVP PRRC2B BAZ2B CAMK2G CECR2 SYT6 PLEKHA4 ZC3H7A DMRTB1 CNOT1 | 8.07e-05 | 430 | 195 | 14 | int:FXR2 |
| Interaction | CAV1 interactions | TNIK ERBB2 SPTBN2 PAK4 ADD1 CLTC FOXO1 FLNA CDC42BPA DSG2 UBXN6 EPB41L5 PTPN23 SPECC1 MICALL1 ROBO2 PEAK1 GARRE1 CXADR | 8.17e-05 | 724 | 195 | 19 | int:CAV1 |
| Interaction | GPBP1 interactions | 8.79e-05 | 75 | 195 | 6 | int:GPBP1 | |
| Interaction | CPEB1 interactions | 8.98e-05 | 146 | 195 | 8 | int:CPEB1 | |
| Interaction | YTHDF3 interactions | PABPC4 GIGYF1 RNF214 RBM47 PRRC2B FOXO1 ZC3H7A DMRTB1 CNOT1 GARRE1 | 1.48e-04 | 246 | 195 | 10 | int:YTHDF3 |
| Interaction | MAPRE1 interactions | PABPC4 ADD1 STIM1 CLTC NAV2 PSRC1 PRRC2B FLNA EML4 CAMK2G PLEKHA4 SPECC1 GAS2L2 PDE4DIP CNOT1 | 1.51e-04 | 514 | 195 | 15 | int:MAPRE1 |
| Interaction | B4GALT2 interactions | 1.60e-04 | 119 | 195 | 7 | int:B4GALT2 | |
| Interaction | MEN1 interactions | ATXN2L GATAD2A ATRX UBE4B PABPC4 PHF8 EMSY KMT2C TCERG1 EIF2B5 C4A MVP PLRG1 CDC42BPA POLR2A PLEKHA4 RELA ATF2 NR2F2 DARS2 NCOR1 YIF1B PPT1 | 1.62e-04 | 1029 | 195 | 23 | int:MEN1 |
| Interaction | FEV interactions | 1.66e-04 | 203 | 195 | 9 | int:FEV | |
| Interaction | CEBPA interactions | ATXN2L GATAD2A ZNF174 PABPC4 ZNF318 INO80D EMSY PHF2 PRAM1 KMT2C TCERG1 CLTC PLRG1 CSTF2T PRRC2B NCOA2 FLNA BAZ2B CAMK2G POLR2A CHD9 ATF2 CREBBP MED15 NCOR1 CNOT1 | 1.76e-04 | 1245 | 195 | 26 | int:CEBPA |
| Interaction | YWHAZ interactions | ATXN2L ERBB2 SPTBN2 PABPC4 PAK4 GIGYF1 WNK1 STIM1 CLTC SIK2 NAV2 TBXA2R FOXO1 TICRR CDC42BPA DSG2 CAMK2G PLEKHA4 PPFIA3 SPECC1 MICALL1 NCOR1 USP8 PPT1 ASXL3 PEAK1 GARRE1 | 1.81e-04 | 1319 | 195 | 27 | int:YWHAZ |
| Interaction | GJA1 interactions | TNIK ERBB2 PAK4 STIM1 CLTC SDK1 FLNA SDK2 CDC42BPA DSG2 EPB41L5 SPECC1 USP8 ROBO2 PEAK1 CXADR | 1.84e-04 | 583 | 195 | 16 | int:GJA1 |
| Interaction | IGBP1 interactions | 1.85e-04 | 162 | 195 | 8 | int:IGBP1 | |
| Interaction | PCDHA8 interactions | 1.89e-04 | 55 | 195 | 5 | int:PCDHA8 | |
| Interaction | RBMS1 interactions | 1.92e-04 | 207 | 195 | 9 | int:RBMS1 | |
| Interaction | STAT6 interactions | 2.00e-04 | 87 | 195 | 6 | int:STAT6 | |
| Interaction | AGO2 interactions | PABPC4 GIGYF1 TRIM66 RNF214 RBM47 PRRC2B RNF31 POLR2A PLEKHA4 DICER1 ZC3H7A PPT1 CNOT1 GARRE1 | 2.13e-04 | 472 | 195 | 14 | int:AGO2 |
| Interaction | TYMP interactions | 2.13e-04 | 88 | 195 | 6 | int:TYMP | |
| Interaction | LHX4 interactions | 2.18e-04 | 166 | 195 | 8 | int:LHX4 | |
| Interaction | LSM14A interactions | ATXN2L GIGYF1 RNF214 TCERG1 RBM47 PRRC2B PLEKHA4 ZC3H7A CNOT1 GARRE1 | 2.31e-04 | 260 | 195 | 10 | int:LSM14A |
| Interaction | C11orf52 interactions | TNIK ERBB2 SPTBN2 PAK4 ADD1 CDC42BPA DSG2 EPB41L5 SPECC1 PEAK1 CXADR | 2.34e-04 | 311 | 195 | 11 | int:C11orf52 |
| Interaction | HDLBP interactions | TNIK ERBB2 GATAD2A UBE4B PABPC4 PHF2 TCERG1 CLTC RBM47 PLRG1 FLNA DSG2 SYT6 UBXN6 PLEKHA4 ANKZF1 SIRT5 ZC3H7A TAF3 NEIL3 | 2.47e-04 | 855 | 195 | 20 | int:HDLBP |
| Interaction | NANOG interactions | ATXN2L GATAD2A ZNF157 EMSY PRAM1 KMT2C USP42 KDM2B CECR2 POLR2A RELA SPECC1 NCOR1 CNOT1 | 2.58e-04 | 481 | 195 | 14 | int:NANOG |
| Interaction | TLN1 interactions | ERBB2 PABPC4 GPKOW USP19 ADD1 CLTC FOXO1 PLEKHA4 ZC3H7A PDE4DIP | 2.61e-04 | 264 | 195 | 10 | int:TLN1 |
| Interaction | POLR1G interactions | GATAD2A ZNF174 PHF8 PHF2 CLTC KDM2B FOXO1 BAZ2B POLR2A PLEKHA4 CHD9 RELA TAF3 ATF7IP | 3.05e-04 | 489 | 195 | 14 | int:POLR1G |
| Interaction | TLE3 interactions | BCL9L ZNF318 INO80D EMSY NCOA2 FLNA BAZ2B CECR2 CREBBP MED15 NCOR1 CSTF2 | 3.14e-04 | 376 | 195 | 12 | int:TLE3 |
| Interaction | PATL1 interactions | 3.36e-04 | 177 | 195 | 8 | int:PATL1 | |
| Interaction | CARM1 interactions | TNIK EMSY NCOA2 FLNA CAMK2G PLEKHA4 RELA IQCN CREBBP PPT1 ASXL3 | 3.40e-04 | 325 | 195 | 11 | int:CARM1 |
| Interaction | CNOT2 interactions | 3.49e-04 | 178 | 195 | 8 | int:CNOT2 | |
| Interaction | TUBGCP6 interactions | 3.59e-04 | 63 | 195 | 5 | int:TUBGCP6 | |
| Interaction | EPG5 interactions | 3.73e-04 | 15 | 195 | 3 | int:EPG5 | |
| Cytoband | 8p23.1 | FAM90A14 FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 1.68e-10 | 154 | 211 | 11 | 8p23.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p23 | FAM90A14 FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 1.38e-08 | 234 | 211 | 11 | chr8p23 |
| GeneFamily | PHD finger proteins | 2.14e-07 | 90 | 126 | 8 | 88 | |
| GeneFamily | Fibronectin type III domain containing | 1.30e-04 | 160 | 126 | 7 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.36e-04 | 161 | 126 | 7 | 593 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 6.01e-04 | 24 | 126 | 3 | 485 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 1.68e-03 | 9 | 126 | 2 | 1234 | |
| GeneFamily | Complement system|Sushi domain containing | 1.99e-03 | 36 | 126 | 3 | 492 | |
| GeneFamily | Glycosyltransferase family 6|Blood group antigens | 2.16e-03 | 37 | 126 | 3 | 454 | |
| GeneFamily | X-linked mental retardation|RNA helicases | 2.54e-03 | 11 | 126 | 2 | 1168 | |
| GeneFamily | RNA binding motif containing | 3.80e-03 | 213 | 126 | 6 | 725 | |
| Coexpression | GSE5503_MLN_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN | 3.42e-06 | 200 | 200 | 10 | M291 | |
| Coexpression | GSE24210_TCONV_VS_TREG_UP | ZNF157 SUSD3 NYNRIN TMEM132A SIK2 PROB1 PSAT1 XBP1 PPFIA3 MAP4K1 | 3.42e-06 | 200 | 200 | 10 | M7851 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | TPR ATXN2L ATRX HIPK1 SUSD3 WNK1 INO80D INPP4B ADD1 STIM1 KMT2C USP42 ST3GAL5 PRRC2B FOXO1 FLNA EML4 YTHDC2 ATF2 CREBBP DICER1 CARD8 NCOR1 PPT1 MAP4K1 ATF7IP PDE4DIP PHF11 CNOT1 | 3.46e-06 | 1492 | 200 | 29 | M40023 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 1.06e-05 | 180 | 200 | 9 | M8239 | |
| Coexpression | GSE15659_RESTING_TREG_VS_NONSUPPRESSIVE_TCELL_DN | 2.36e-05 | 199 | 200 | 9 | M3560 | |
| Coexpression | GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP | 2.36e-05 | 199 | 200 | 9 | M7254 | |
| Coexpression | GSE8621_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN | 2.36e-05 | 199 | 200 | 9 | M6987 | |
| Coexpression | FORTSCHEGGER_PHF8_TARGETS_DN | IGFN1 GATAD2A HIPK1 ZNF318 PHF8 MAGEF1 PRRT3 NAV2 STRA6 MVP CSTF2T PRRC2B SIRT5 USF3 YIF1B TNS4 FBLIM1 CXADR | 3.43e-05 | 783 | 200 | 18 | M2488 |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | IGFN1 SCARF2 NAV2 SDK1 S1PR3 NR2F2 ADAMTS12 ASXL3 ROBO2 TMEM108 | 1.44e-08 | 187 | 201 | 10 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-07 | 191 | 201 | 9 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-07 | 191 | 201 | 9 | 60bc1f3efa7bbad5cb7944fe5e049ea79cd1745a | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-07 | 191 | 201 | 9 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-07 | 191 | 201 | 9 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-07 | 194 | 201 | 9 | 8ef0b71fef5b84cfd04973f891215333e7035d1d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.58e-07 | 194 | 201 | 9 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.58e-07 | 194 | 201 | 9 | df82cce5ebeb73740b02cf816c6df82253cfd566 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.94e-07 | 197 | 201 | 9 | 80e153790cef37b743e22a7370ff5b3a6abf147d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.07e-07 | 198 | 201 | 9 | 8b9e8eaeffda40912a0163fdf39b93bc5e64751c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.07e-07 | 198 | 201 | 9 | eb78b2ae6a787dbc75947e8dd5a03693285bc8be | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.13e-06 | 186 | 201 | 8 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 2.22e-06 | 187 | 201 | 8 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-06 | 187 | 201 | 8 | accb8a78b885703a27d4b560f0053f03d82ff3af | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-06 | 191 | 201 | 8 | ff7874cc005760a8f3b2e8072fbe418b6bfacaa8 | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-06 | 191 | 201 | 8 | 5c1f5b6c115b1b27b4a7467a6550ce43c01cf6d0 | |
| ToppCell | droplet-Trachea-3m-Epithelial-airway_epithelial-neuroendocrine_cell-neuroendocrine|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.60e-06 | 191 | 201 | 8 | 72f1ddc09080dbfea8d51294cbf7f9d4925f9cc0 | |
| ToppCell | droplet-Trachea-3m-Epithelial-airway_epithelial-neuroendocrine_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.60e-06 | 191 | 201 | 8 | 6e7f589efc997f32175e0789c5ea7ca46e1389b8 | |
| ToppCell | droplet-Trachea-nan-3m-Epithelial-neuroendocrine_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-06 | 191 | 201 | 8 | 3ce403e0beedb544edeb3ae6eb30267040d00c21 | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-06 | 192 | 201 | 8 | eb9a0b3d32f90f8b95905c740aab21639dae5cbd | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 2.70e-06 | 192 | 201 | 8 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-06 | 193 | 201 | 8 | 1043b28503bfaa0d5a82ec358bc86cbde73ea8f2 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-06 | 193 | 201 | 8 | b9e11cd0896c0868aab7faec4ab7ab4d4e4d1b47 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.81e-06 | 193 | 201 | 8 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-06 | 193 | 201 | 8 | 0266a4fdf436d83ec1d9392abba8c6ec5166970a | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 2.81e-06 | 193 | 201 | 8 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.92e-06 | 194 | 201 | 8 | 81713e0409e8be695ba5dfdc67a997b33435dd9e | |
| ToppCell | LV-10._Endothelium_II|LV / Chamber and Cluster_Paper | 2.92e-06 | 194 | 201 | 8 | b6cc849fa08599bff9839ef382d190cc964e273e | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-06 | 194 | 201 | 8 | 52ecec2618c3bb5fdd7fb06b5a40bd6f0aedfe1d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.92e-06 | 194 | 201 | 8 | 627cffe2d448e74fc5df92e74e5b922a73304137 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area|World / Primary Cells by Cluster | 3.27e-06 | 197 | 201 | 8 | 79b9e7f2e8e33b3c547f716be5667156c48b0dfc | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area-33|World / Primary Cells by Cluster | 3.27e-06 | 197 | 201 | 8 | d20f29088e9afd8a960d6f680075c380e550f8a7 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.27e-06 | 197 | 201 | 8 | 4a04da876a1482604452ae53c124ae68eda0bd5e | |
| ToppCell | (0)_Normal/No_Treatment-(4)_COL2.3+_osteoblasts|World / Stress and Cell class | 4.80e-06 | 147 | 201 | 7 | 87c24843cb0e87ad42e725d08423131a5d2d25a3 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.40e-06 | 157 | 201 | 7 | d85a2f56ae313baa9738e81d2756ce1fe1ba50db | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Mesenchymal|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 8.04e-06 | 159 | 201 | 7 | f34f2729a3872fbb2939e76ad35d7e25f71b8f57 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Mesenchymal-Unfolded_protein_responsible_cell|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 8.04e-06 | 159 | 201 | 7 | 929ed98f6c2ad14e8d5af5c6f11a5a3d4b388cf7 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.11e-05 | 167 | 201 | 7 | 784776d1fcc098f84d3c2eca58fa56cb9428f434 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 1.34e-05 | 172 | 201 | 7 | c62cad0f4212d1e9ea1ec3143ad3c4e06aff0ebf | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.34e-05 | 172 | 201 | 7 | 858cee96c1c06160863b4adcd7023c0d678bd50f | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.50e-05 | 175 | 201 | 7 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.50e-05 | 175 | 201 | 7 | 15c69dd5635c9251c535f1e22467712e9667ae92 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.61e-05 | 177 | 201 | 7 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.67e-05 | 178 | 201 | 7 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-05 | 178 | 201 | 7 | 416f85e51f45ec7949451fd47611a84e33e87245 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-05 | 178 | 201 | 7 | 78a0c6340001a77f5b2d890b6263f574af2e72da | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteochondral_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.74e-05 | 179 | 201 | 7 | 98c0c5c8034ae8a4b3ceea7fd1d0386ee5f89d09 | |
| ToppCell | COVID-19-Heart-Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.86e-05 | 181 | 201 | 7 | 33cac65ed1ea5e7bd72250495df4f850b143d5aa | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.86e-05 | 181 | 201 | 7 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-05 | 181 | 201 | 7 | 7af469f5bcb9b1ab3f35b2758bf2afb87e8eba57 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-05 | 182 | 201 | 7 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-05 | 182 | 201 | 7 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 2.00e-05 | 183 | 201 | 7 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | LA-07._Pericyte|World / Chamber and Cluster_Paper | 2.00e-05 | 183 | 201 | 7 | e3835db4795362b0442d5893baf2a78efcc20428 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.00e-05 | 183 | 201 | 7 | 8a799807fbf24456a9811e0c64068187940a2f71 | |
| ToppCell | LV-07._Pericyte|World / Chamber and Cluster_Paper | 2.00e-05 | 183 | 201 | 7 | 273db6a3b00a93ca852498471187b642b5368185 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-05 | 184 | 201 | 7 | 89ae8bf1a6c2d355d279d23a5e24a08d9ec2334e | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-05 | 184 | 201 | 7 | 34c84ac9a32eaf96f45b79485119cad65905817d | |
| ToppCell | LA-07._Pericyte|LA / Chamber and Cluster_Paper | 2.15e-05 | 185 | 201 | 7 | ba5baa4d7f097108622674de5b7f4fd279843d24 | |
| ToppCell | Control-Epithelial_alveolar|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.15e-05 | 185 | 201 | 7 | 3937e026add96a396122139daf8011cfbc60e75c | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.22e-05 | 186 | 201 | 7 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | LPS-IL1RA-Unknown-Endothelial-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.23e-05 | 125 | 201 | 6 | 2938a1d62afe1e0a3abba5eb92f07b886cc0accd | |
| ToppCell | droplet-Heart-4Chambers-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.30e-05 | 187 | 201 | 7 | dba4924d914a7dcd4901142684ba920c2404860b | |
| ToppCell | droplet-Heart-4Chambers-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.30e-05 | 187 | 201 | 7 | 9688141beef4f62613d7a810c5872ccb9afc1a71 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.30e-05 | 187 | 201 | 7 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | Pericytes-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 2.38e-05 | 188 | 201 | 7 | f16ff998393bf1954bbf10caab15173bdb104ac1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-05 | 189 | 201 | 7 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-05 | 189 | 201 | 7 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal-Neuron|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 2.46e-05 | 189 | 201 | 7 | 3717d1148e26ac78a26aea0ca1dbfbb9d3668877 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 2.46e-05 | 189 | 201 | 7 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.55e-05 | 190 | 201 | 7 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 2.55e-05 | 190 | 201 | 7 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.55e-05 | 190 | 201 | 7 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.63e-05 | 191 | 201 | 7 | a6c57627077fa980b7ec1d3894b5f31bfb11b738 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.63e-05 | 191 | 201 | 7 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.63e-05 | 191 | 201 | 7 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.63e-05 | 191 | 201 | 7 | 8f6d592edc32fdb901af30501d4360512334e8c2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.63e-05 | 191 | 201 | 7 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-05 | 192 | 201 | 7 | bc84b9ce01b4d826a682842ab8a395dac9b91183 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-05 | 192 | 201 | 7 | 0bb06738e1c3ec0c044a7ee61f6cf1d4781fb53c | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.72e-05 | 192 | 201 | 7 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-05 | 192 | 201 | 7 | 88472b99970ba0decbf87164fc241a1c77b3b389 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.72e-05 | 192 | 201 | 7 | 71863f18a82394ed9f8e5ec8a4017215382a8284 | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-smooth_muscle_cell_of_trachea|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-05 | 192 | 201 | 7 | a804cb101c3a5585f72217e1143584b1ca436724 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-05 | 192 | 201 | 7 | 0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l39|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.81e-05 | 193 | 201 | 7 | d0dcc0c11ccf99ff6b07e456d25b9742649aadd8 | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 2.81e-05 | 193 | 201 | 7 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 2.81e-05 | 193 | 201 | 7 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | 18-Airway-Mesenchymal-Pericyte|Airway / Age, Tissue, Lineage and Cell class | 2.81e-05 | 193 | 201 | 7 | 9f4ba9c29ab8071d57e4187085ec3a47ab61e968 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.91e-05 | 194 | 201 | 7 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.91e-05 | 194 | 201 | 7 | 04bfc555743f7d8821439d05ae442d15e9886c59 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.91e-05 | 194 | 201 | 7 | a7731378f44ca1a229311686caf5740c742d21ba | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.91e-05 | 194 | 201 | 7 | 71d3c7448b1734de54187f902f65649f9283bd4c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.91e-05 | 194 | 201 | 7 | 69bff17df4a760ccf081cf52ff04af02c14f448d | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-05 | 194 | 201 | 7 | b8a130ffae68ffe550bf335460a1ec1035cf8d8d | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|lung / Disease (COVID-19 only), tissue and cell type | 2.91e-05 | 194 | 201 | 7 | 5e1e0513a54ec4cf0b247ec85c9fbc68dfac1da3 | |
| ToppCell | Differ-Basal|World / shred by cell class for mouse tongue | 2.91e-05 | 194 | 201 | 7 | 851eff82c9f3d44c86e3e127a804bbd1fced6a7c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.01e-05 | 195 | 201 | 7 | cad6563cc51d212554152c727fc2c249c6a07e4d | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 3.01e-05 | 195 | 201 | 7 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.01e-05 | 195 | 201 | 7 | 783bfa8110161cbd6def50ce849cae676c39c458 | |
| Drug | (+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Down 200; 11uM; MCF7; HT_HG-U133A | ATXN2L CAMTA2 TSC22D2 STIM1 CSTF2T HSPG2 CDC42BPA EPB41L5 CR1 SIRT5 GARRE1 | 1.24e-06 | 194 | 200 | 11 | 3384_DN |
| Drug | Bupropion hydrochloride [31677-93-7]; Up 200; 14.4uM; HL60; HG-U133A | UBE4B SSBP2 PHF8 ADD1 ST3GAL5 STRA6 CSTF2T PRRC2B CR1 NR2F2 NCOR1 | 1.44e-06 | 197 | 200 | 11 | 1564_UP |
| Drug | Hydrastine hydrochloride [5936-28-7]; Up 200; 9.6uM; HL60; HG-U133A | TNIK SSBP2 WNK1 CHRM4 USP19 TBXA2R CDC42BPA ITGA10 SIRT5 ADAMTS12 DIP2C | 1.51e-06 | 198 | 200 | 11 | 1740_UP |
| Drug | genistein; Down 200; 10uM; MCF7; HT_HG-U133A | ZNF174 SSBP2 MAGEF1 ST3GAL5 NDUFAF7 CSTF2T NCOA2 CDC42BPA RNF31 RTL10 | 9.69e-06 | 196 | 200 | 10 | 6994_DN |
| Drug | Etofenamate [30544-47-9]; Down 200; 10.8uM; HL60; HT_HG-U133A | ATXN2L ZNF318 SIK2 PRRC2B NCOA2 CDC42BPA MICALL1 PWWP3A NEIL3 GARRE1 | 9.69e-06 | 196 | 200 | 10 | 2907_DN |
| Drug | LY 294002; Down 200; 0.1uM; PC3; HT_HG-U133A | UBE4B BCAS3 CAMTA2 MAGEF1 PHF2 TRIM66 MVP PPFIA3 SIRT5 NR2F2 | 9.69e-06 | 196 | 200 | 10 | 1216_DN |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | UBE4B TSC22D2 PHF8 STIM1 NDUFAF7 CSTF2T PRRC2B CDC42BPA MED15 PDE4DIP | 1.01e-05 | 197 | 200 | 10 | 3566_DN |
| Drug | Bisacodyl [603-50-9]; Down 200; 11uM; HL60; HT_HG-U133A | GALNT2 UBE4B ZNF174 SSBP2 WNK1 INPP4B RBM47 EML4 NR2F2 MAP4K1 | 1.01e-05 | 197 | 200 | 10 | 2435_DN |
| Drug | fluphenazine dihydrochloride; Down 200; 10uM; PC3; HT_HG-U133A | CAMTA2 MAGEF1 PHF2 TMEM132A PRRC2B TBXA2R RNF31 SIRT5 MED15 ZNF8 | 1.06e-05 | 198 | 200 | 10 | 1237_DN |
| Drug | 1H,1H,2H,2H-perfluorooctan-1-ol | 2.28e-05 | 7 | 200 | 3 | CID000069537 | |
| Drug | 8:2 FTOH | 2.28e-05 | 7 | 200 | 3 | CID000069619 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.67e-05 | 176 | 200 | 9 | 1212_DN | |
| Drug | prochloraz | ERBB2 SPTBN2 PAK4 PGR ZAR1 NOTCH3 ACSS3 CACNA1B CAMK2G UBXN6 TAF3 | 2.68e-05 | 268 | 200 | 11 | ctd:C045362 |
| Drug | 1H,1H,2H,2H-perfluorooctan-1-ol | 3.62e-05 | 8 | 200 | 3 | ctd:C508406 | |
| Drug | Dihydroergotamine tartrate [5989-77-5]; Down 200; 3uM; PC3; HT_HG-U133A | 5.27e-05 | 192 | 200 | 9 | 2081_DN | |
| Drug | Mebeverine hydrochloride [2753-45-9]; Up 200; 8.6uM; PC3; HT_HG-U133A | 5.49e-05 | 193 | 200 | 9 | 7147_UP | |
| Drug | Pyrithyldione [77-04-3]; Down 200; 24uM; PC3; HT_HG-U133A | TNIK NRXN3 ST3GAL5 POLR2A PPFIA3 ADAMTSL3 CARD8 NCOR1 GARRE1 | 5.49e-05 | 193 | 200 | 9 | 7153_DN |
| Drug | AC1L9M2J | 5.59e-05 | 76 | 200 | 6 | CID000448538 | |
| Drug | Chicago sky blue 6B [2610-05-1]; Down 200; 4uM; HL60; HT_HG-U133A | 5.94e-05 | 195 | 200 | 9 | 1330_DN | |
| Drug | Oxethazaine [126-27-2]; Up 200; 8.6uM; PC3; HG-U133A | 5.94e-05 | 195 | 200 | 9 | 1903_UP | |
| Drug | Protriptyline hydrochloride [1225-55-4]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 6.18e-05 | 196 | 200 | 9 | 5438_DN | |
| Drug | Benzonatate [104-31-4]; Down 200; 6.6uM; HL60; HT_HG-U133A | 6.18e-05 | 196 | 200 | 9 | 1843_DN | |
| Drug | CAY10397; Down 200; 10uM; PC3; HT_HG-U133A | 6.18e-05 | 196 | 200 | 9 | 7087_DN | |
| Drug | Chlormezanone [80-77-3]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 6.43e-05 | 197 | 200 | 9 | 3235_DN | |
| Drug | Ketorolac tromethamine [74103-07-4]; Down 200; 10.6uM; PC3; HT_HG-U133A | 6.43e-05 | 197 | 200 | 9 | 7286_DN | |
| Drug | Meticrane [1084-65-7]; Down 200; 14.6uM; PC3; HT_HG-U133A | ERBB2 TRIM66 ST3GAL5 TMEM132A CSTF2T PPFIA3 SIRT5 NR2F2 NCOR1 | 6.43e-05 | 197 | 200 | 9 | 7282_DN |
| Drug | Sulfadimethoxine [122-11-2]; Down 200; 12.8uM; MCF7; HT_HG-U133A | CAMTA2 TSC22D2 XYLT2 ADRA1D ST3GAL5 NCOA2 CDC42BPA RNF31 PDE4DIP | 6.68e-05 | 198 | 200 | 9 | 3441_DN |
| Drug | Naloxone hydrochloride [357-08-4]; Down 200; 11uM; MCF7; HT_HG-U133A | MAGEF1 XYLT2 TRIM66 STRA6 CAMK2G RTL10 EPB41L5 YTHDC2 PDE4DIP | 6.68e-05 | 198 | 200 | 9 | 1506_DN |
| Drug | Merbromin [129-16-8]; Down 200; 5uM; PC3; HT_HG-U133A | 6.95e-05 | 199 | 200 | 9 | 7398_DN | |
| Drug | Procainamide hydrochloride [614-39-1]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 6.95e-05 | 199 | 200 | 9 | 2618_DN | |
| Drug | Homochlorcyclizine dihydrochloride [1982-36-1]; Down 200; 10.4uM; PC3; HT_HG-U133A | 6.95e-05 | 199 | 200 | 9 | 7295_DN | |
| Drug | AC1LA234 | 7.66e-05 | 10 | 200 | 3 | CID000480136 | |
| Disease | Adenocarcinoma of lung (disorder) | 7.51e-05 | 206 | 196 | 8 | C0152013 | |
| Disease | nasal disorder | 8.41e-05 | 35 | 196 | 4 | MONDO_0002436 | |
| Disease | Agents acting on the renin-angiotensin system use measurement | LINC00322 BCAS3 ZNF318 TSC22D2 ADRA1D SIK2 KDM2B TICRR RASSF10 JPH2 | 8.83e-05 | 335 | 196 | 10 | EFO_0009931 |
| Disease | Impaired cognition | 9.95e-05 | 14 | 196 | 3 | C0338656 | |
| Disease | Carcinoma, Transitional Cell | 1.58e-04 | 41 | 196 | 4 | C0007138 | |
| Disease | FEV/FEC ratio | SCARF2 BCAS3 AMZ1 PABPC4 INPP4B STIM1 PHF2 NAV2 FOXO1 HSPG2 EML4 CAMK2G EPB41L5 RASSF10 ADAMTSL3 NR2F2 LDB2 MED15 USP8 CXADR | 2.11e-04 | 1228 | 196 | 20 | EFO_0004713 |
| Disease | polycystic ovary syndrome (biomarker_via_orthology) | 3.51e-04 | 21 | 196 | 3 | DOID:11612 (biomarker_via_orthology) | |
| Disease | visceral adipose tissue measurement | PDE4C ARPP21 SSBP2 WNK1 PHF2 TRIM66 NRXN3 PSAT1 RASSF10 IQCN ROBO2 | 4.00e-04 | 481 | 196 | 11 | EFO_0004765 |
| Disease | cortical thickness | TNIK GATAD2A SPTBN2 ZNF318 TSC22D2 ZNF469 PMPCA NAV2 NCOA2 HSPG2 FSD2 ADAMTSL3 SPECC1 NR2F2 MICALL1 KIAA1755 ROBO2 TMEM108 | 4.79e-04 | 1113 | 196 | 18 | EFO_0004840 |
| Disease | Intrahepatic Cholangiocarcinoma | 5.27e-04 | 24 | 196 | 3 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 5.27e-04 | 24 | 196 | 3 | C3805278 | |
| Disease | medial orbital frontal cortex volume measurement | 5.96e-04 | 25 | 196 | 3 | EFO_0010315 | |
| Disease | polycystic ovary syndrome (implicated_via_orthology) | 6.47e-04 | 6 | 196 | 2 | DOID:11612 (implicated_via_orthology) | |
| Disease | renal overload-type gout | 6.47e-04 | 6 | 196 | 2 | EFO_0021525 | |
| Disease | Cholangiocarcinoma | 6.70e-04 | 26 | 196 | 3 | C0206698 | |
| Disease | severe acute respiratory syndrome, COVID-19 | SCARF2 AMMECR1L NCOA2 CECR2 LDB2 MICALL1 ADAMTS12 MED15 PDE4DIP FBLIM1 | 8.64e-04 | 447 | 196 | 10 | EFO_0000694, MONDO_0100096 |
| Disease | Malignant neoplasm of breast | ERBB2 SCARF2 SUSD3 ZNF318 WNK1 EMSY INPP4B PGR NOTCH3 NCOA2 FLNA XBP1 RELA ATF2 MICALL1 NCOR1 DIP2C | 8.71e-04 | 1074 | 196 | 17 | C0006142 |
| Disease | fish consumption measurement | 8.79e-04 | 64 | 196 | 4 | EFO_0010139 | |
| Disease | Developmental regression | 9.02e-04 | 7 | 196 | 2 | C1836830 | |
| Disease | level of oxylipin in blood plasma | 9.02e-04 | 7 | 196 | 2 | OBA_2050338 | |
| Disease | Diuretic use measurement | 9.61e-04 | 169 | 196 | 6 | EFO_0009928 | |
| Disease | cardiovascular disease | LINC00322 BCAS3 ZNF318 TSC22D2 RNF214 ADRA1D ST3GAL5 KDM2B RASSF10 JPH2 | 1.02e-03 | 457 | 196 | 10 | EFO_0000319 |
| Disease | renal cell carcinoma (is_implicated_in) | 1.17e-03 | 69 | 196 | 4 | DOID:4450 (is_implicated_in) | |
| Disease | eosinophil cationic protein measurement | 1.20e-03 | 8 | 196 | 2 | EFO_0010913 | |
| Disease | syndromic X-linked intellectual disability (implicated_via_orthology) | 1.20e-03 | 8 | 196 | 2 | DOID:0060309 (implicated_via_orthology) | |
| Disease | beta-defensin 119 measurement | 1.20e-03 | 8 | 196 | 2 | EFO_0801419 | |
| Disease | monocyte percentage of leukocytes | WNK1 ADD1 PMPCA ST3GAL5 RBM47 SERTAD1 FOXO1 CDC42BPA CECR2 CHD9 S1PR3 USP8 KIAA1755 | 1.28e-03 | 731 | 196 | 13 | EFO_0007989 |
| Disease | mitral valve prolapse (is_implicated_in) | 1.53e-03 | 9 | 196 | 2 | DOID:988 (is_implicated_in) | |
| Disease | Liver Diseases, Parasitic | 1.53e-03 | 9 | 196 | 2 | C0023897 | |
| Disease | BMI-adjusted waist-hip ratio, adult onset asthma | 1.53e-03 | 9 | 196 | 2 | EFO_0007788, EFO_1002011 | |
| Disease | longitudinal alcohol consumption measurement | 1.53e-03 | 9 | 196 | 2 | EFO_0007645 | |
| Disease | triacylglycerol 52:4 measurement | 1.75e-03 | 36 | 196 | 3 | EFO_0010416 | |
| Disease | platelet crit | GALNT2 GATAD2A ATRX BCAS3 INPP1 AMZ1 SUSD3 SSBP2 ZNF318 NOTCH3 NCOA2 FOXO1 EPB41L5 JPH2 DCHS1 | 1.83e-03 | 952 | 196 | 15 | EFO_0007985 |
| Disease | neuroimaging measurement | TNIK ATXN2L GATAD2A AMZ1 TSC22D2 ZNF469 NAV2 PDXDC2P CDC42BPA CAMK2G MSH5 NR2F2 NCOR1 PABPC3 KIAA1755 ROBO2 | 2.17e-03 | 1069 | 196 | 16 | EFO_0004346 |
| Disease | pars orbitalis volume measurement | 2.32e-03 | 11 | 196 | 2 | EFO_0010320 | |
| Disease | pro‐interleukin‐16 measurement | 2.32e-03 | 11 | 196 | 2 | EFO_0010629 | |
| Disease | Bipolar I disorder | 2.32e-03 | 11 | 196 | 2 | C0853193 | |
| Disease | waist circumference | ATXN2L TSC22D2 STIM1 TRIM66 NRXN3 NAV2 ADAMTSL3 LDB2 TMEM108 | 2.40e-03 | 429 | 196 | 9 | EFO_0004342 |
| Disease | Schizophrenia | TNIK GPR50 SPTBN2 CHRM4 NRXN3 KDM2B CACNA1B PSAT1 XBP1 RELA ADAMTSL3 DICER1 ADAMTS12 MED15 | 2.44e-03 | 883 | 196 | 14 | C0036341 |
| Disease | Bladder Neoplasm | 2.48e-03 | 140 | 196 | 5 | C0005695 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 2.56e-03 | 41 | 196 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 2.56e-03 | 41 | 196 | 3 | C0858252 | |
| Disease | Malignant neoplasm of urinary bladder | 2.56e-03 | 141 | 196 | 5 | C0005684 | |
| Disease | rac GTPase-activating protein 1 measurement | 2.77e-03 | 12 | 196 | 2 | EFO_0801985 | |
| Disease | Prostatic Neoplasms | ERBB2 SSBP2 KMT2C TAF1L NCOA2 FOXO1 RNF31 PCDH11Y CREBBP NCOR1 ROBO2 | 2.89e-03 | 616 | 196 | 11 | C0033578 |
| Disease | Malignant neoplasm of prostate | ERBB2 SSBP2 KMT2C TAF1L NCOA2 FOXO1 RNF31 PCDH11Y CREBBP NCOR1 ROBO2 | 2.89e-03 | 616 | 196 | 11 | C0376358 |
| Disease | egg allergy measurement, parental genotype effect measurement | 3.26e-03 | 13 | 196 | 2 | EFO_0005939, EFO_0007018 | |
| Disease | putamen volume change measurement | 3.26e-03 | 13 | 196 | 2 | EFO_0021495 | |
| Disease | serum gamma-glutamyl transferase measurement | TNIK PDE4C ARPP21 ATRX EMSY NAV2 KDM2B PSRC1 ACSS3 CDC42BPA EML4 CAMK2G CHD9 FBLIM1 | 3.32e-03 | 914 | 196 | 14 | EFO_0004532 |
| Disease | fibrinogen measurement, tissue plasminogen activator measurement | 3.34e-03 | 45 | 196 | 3 | EFO_0004623, EFO_0004791 | |
| Disease | S-6-hydroxywarfarin measurement | 3.34e-03 | 368 | 196 | 8 | EFO_0803326 | |
| Disease | Neurodevelopmental Disorders | 3.48e-03 | 93 | 196 | 4 | C1535926 | |
| Disease | body surface area | PDE4C WNK1 SPATA31C1 TRIM66 NRXN3 FOXO1 TICRR SPATA31C2 ADAMTSL3 DICER1 GPR156 | 3.99e-03 | 643 | 196 | 11 | EFO_0022196 |
| Disease | Adenoid Cystic Carcinoma | 4.51e-03 | 100 | 196 | 4 | C0010606 | |
| Disease | body weight | ATXN2L AMZ1 SSBP2 TSC22D2 SPATA31C1 TRIM66 NRXN3 FOXO1 CACNA1B SPATA31C2 PPFIA3 ADAMTSL3 LDB2 NCOR1 USF3 SUSD1 ASXL3 | 4.61e-03 | 1261 | 196 | 17 | EFO_0004338 |
| Disease | Spondyloepiphyseal Dysplasia | 4.95e-03 | 16 | 196 | 2 | C0038015 | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 4.95e-03 | 16 | 196 | 2 | C3541456 | |
| Disease | amygdala volume change measurement | 4.95e-03 | 16 | 196 | 2 | EFO_0021490 | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 4.95e-03 | 16 | 196 | 2 | C4551479 | |
| Disease | Schwartz-Jampel Syndrome | 4.95e-03 | 16 | 196 | 2 | C0036391 | |
| Disease | Melnick-Needles Syndrome | 4.95e-03 | 16 | 196 | 2 | C0025237 | |
| Disease | Huntington's disease (is_marker_for) | 5.30e-03 | 53 | 196 | 3 | DOID:12858 (is_marker_for) | |
| Disease | Small cell carcinoma of lung | 5.58e-03 | 54 | 196 | 3 | C0149925 | |
| Disease | S-adenosylhomocysteine measurement | 5.59e-03 | 17 | 196 | 2 | EFO_0010531 | |
| Disease | Van Buchem disease | 5.59e-03 | 17 | 196 | 2 | C0432272 | |
| Disease | Diffuse Large B-Cell Lymphoma | 5.88e-03 | 55 | 196 | 3 | C0079744 | |
| Disease | mortality | 6.10e-03 | 173 | 196 | 5 | EFO_0004352 | |
| Disease | fibrinogen measurement | 6.11e-03 | 109 | 196 | 4 | EFO_0004623 | |
| Disease | blood phosphate measurement | 6.24e-03 | 174 | 196 | 5 | EFO_0010972 | |
| Disease | Glioblastoma Multiforme | 6.51e-03 | 111 | 196 | 4 | C1621958 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RPSAPQQGRRQPSMP | 21 | A8MWP4 | |
| AIEIVPATPAGMRPA | 356 | P08173 | |
| PATPAGMRPAANVAR | 361 | P08173 | |
| DMSAQEPPQGRRFPI | 51 | H3BQW9 | |
| LVEPLTPSGAMPNQA | 696 | P04626 | |
| PAVQPSGPINMEETR | 661 | Q9Y2D5 | |
| ITRMNPASGALSPLP | 76 | Q6DCA0 | |
| EMFTGQLPATRQDPP | 441 | Q400G9 | |
| RTLEIPGNSDPNMIP | 956 | P0C0L5 | |
| APAMPDFQPGDTTVR | 1946 | Q68DQ2 | |
| GRRTPGNQTPVMPSA | 541 | Q9UIF8 | |
| PRSLPAAMATPAVSG | 231 | Q7L3V2 | |
| NVQLPQAPMGPRAAS | 731 | Q92793 | |
| AAVAGPRMPSVQPPR | 2046 | Q92793 | |
| PQADPRPSMSLAVVV | 346 | O94983 | |
| GIPVRTAPAAAVSPM | 851 | Q5M775 | |
| LPNGQTMPVAIPASI | 221 | P15336 | |
| SQTAMFLPPTVPGAR | 241 | Q7Z5J1 | |
| INSPLRASIVGPPMS | 671 | Q9UPY3 | |
| MQRGSLPANVPTPRG | 306 | P33240 | |
| RIQPVRSDPVSMPGS | 791 | Q9H6U6 | |
| QRNVTRMGSQPPDPN | 1061 | Q00975 | |
| QAPFLNQMRPAVPGT | 641 | Q9BXF3 | |
| QPFTMQPPVGINSLR | 686 | Q9BXF3 | |
| QMVKSARPVAEPNPG | 131 | Q4G0W2 | |
| PQMGRRTPAQVPSVD | 346 | A6NDY2 | |
| NPPTSQQPLRSAMVG | 501 | Q9UBL0 | |
| SSVLIPPMGINNRFP | 1356 | Q9C0F0 | |
| PPFSTVMEGLLPSQR | 1211 | P58397 | |
| INGGPSRMSPKAQRP | 401 | Q8WWM7 | |
| PARGAPARPSLAMTQ | 156 | A6NK89 | |
| MISPIAVQPDPASAA | 476 | A0AV96 | |
| MAGIPGRESNAPSVP | 236 | Q8NBR0 | |
| PQISMPQEVRVPAGS | 3576 | P98160 | |
| REAVQRGRMPPTQPT | 146 | P24468 | |
| VGVTKPSPQTRLPAM | 486 | Q9H0B3 | |
| PQFSGPELAMAVRPA | 866 | Q9H3S7 | |
| PQMGRRTPAQVPSVD | 346 | A6NKC0 | |
| ATPLPDPMASRNVIA | 921 | Q14126 | |
| PQASSQVVMPPLVRG | 236 | Q86YP4 | |
| PQMGRRTPAQVPSVD | 346 | A8MXZ1 | |
| FQGMPSAIRQSGPRP | 446 | Q13310 | |
| RKAEAAPGPMSQAAP | 2966 | Q96JQ0 | |
| GRPQLQGAPAAEPMA | 176 | P51606 | |
| VSGLPMPSRAPVASV | 131 | Q96EL1 | |
| PLMGVINQPFVSRDP | 196 | P49441 | |
| ERMAIEALQAPPAPS | 541 | Q9BR39 | |
| PFIAPPGRVLDNAMN | 2956 | Q8NEZ4 | |
| MAVQRAASPRRPPAP | 1 | Q8IVU1 | |
| MLQTPESRGLPVPQA | 1 | Q9HAY2 | |
| PPRGGDQNLLPTMSR | 621 | O75420 | |
| INMTDGPRTLNPDSP | 491 | Q8TAT5 | |
| GFPVRMDNAVPIVPQ | 671 | Q86Z02 | |
| NPENMVQLRPGPRQA | 406 | Q5JYT7 | |
| GVTPDSAEMLPPNFR | 1141 | O75145 | |
| SPQDQPPVMRGQDSI | 496 | O15327 | |
| RSRQGNPVAPIKTPM | 291 | Q10471 | |
| MRVSVPGPAAAAAPA | 1 | Q8N3F9 | |
| RMVAPPAEPTRQPTT | 241 | O43679 | |
| TPMNVRNVPLPGDAA | 361 | Q13585 | |
| GIPEQTVMQPVSPSR | 151 | Q5VYM1 | |
| MAAPVVAPPGVVVSR | 1 | Q13144 | |
| AAADMPQPAVRHQGP | 206 | A8MWA6 | |
| PQMGRRTPAQVPSVD | 346 | A8MWA6 | |
| PQMGRRTPAQVPSVD | 346 | P0C7W9 | |
| PGASDRPQPTAMNSI | 151 | O43660 | |
| DPQSSPGLGRIMQAP | 96 | Q08493 | |
| GQSRAAMIPPKQPRQ | 1111 | Q9H792 | |
| AVPVPNMTPSAVGRE | 406 | Q6P474 | |
| RVAPAMALTPPQGDA | 1761 | Q9UM47 | |
| PSSSIPLGRQPMAQV | 411 | Q96RN5 | |
| EAQALTPTGPSRMPR | 211 | Q92917 | |
| VEQMPQASPGLAPRT | 571 | Q8N3F8 | |
| PVMGATRSNLQPPRK | 341 | Q6PGN9 | |
| PQMGRRTPAQVPSVD | 346 | P0DV74 | |
| PQMGRRTPAQVPSVD | 346 | P0DV73 | |
| PQMGRRTPAQVPSVD | 346 | P0DV76 | |
| GMALPRPRDQAVFPQ | 616 | Q14764 | |
| SAIRPGAPRVPFSTM | 446 | Q9H361 | |
| NVGLRPPMVPRQASF | 21 | Q7L5N7 | |
| QRCPSPPMINLISVG | 126 | P50897 | |
| ALVEQDAPMAPGRSP | 281 | P06401 | |
| PQMGRRTPAQVPSID | 346 | A6NJQ4 | |
| TMRFNIPTGTNLPPV | 2286 | P46100 | |
| GERNIPRVMSPENFP | 541 | Q3L8U1 | |
| NVIESPGLNVMRVPP | 546 | Q9HCM4 | |
| PQRASDQARPGPEIM | 1471 | Q14674 | |
| IMTPVDPGVAQPNSR | 476 | Q12778 | |
| MRDLLSPPTDNRPGQ | 1191 | Q8NHM5 | |
| QGSPDPQQTPSRMGR | 306 | Q0VDD7 | |
| RKSCRNPPDPVNGMV | 101 | P17927 | |
| QVPGPLTPEMEARQA | 601 | Q9H8Y5 | |
| PSERAAVAMPSLAGP | 146 | Q96MA1 | |
| PLLARQSPATSVGMP | 131 | Q6ZN03 | |
| PGLSPGMVRANLPQS | 1456 | P21333 | |
| PMPRVGVSCNGAAQP | 91 | Q8NHY3 | |
| PPAKVAAPNLSRMGA | 336 | P78310 | |
| EAQQTGRRQTPPQPM | 321 | O15063 | |
| LSNMEQGTLPPSGPR | 1036 | Q86UU0 | |
| GVRLQTSPPMEPLNF | 356 | Q9Y2G2 | |
| PMVRPGDRVALVFPN | 376 | Q9Y2E4 | |
| RSVMEAPFPAPGRTI | 626 | Q68D51 | |
| PAQAPLRGTVMQAPA | 1071 | Q6VMQ6 | |
| MPSQRSRGPLAPNHV | 26 | Q8N112 | |
| VRPHPAQRIAAASMP | 591 | O75578 | |
| PGRAAATVPAAPMQL | 66 | Q8WUP2 | |
| VPQGNLSMPASVSLP | 566 | Q53TQ3 | |
| RGDQVPMNPSQSLLP | 501 | Q8NFN8 | |
| PMNPSQSLLPERGGS | 506 | Q8NFN8 | |
| QLMPVGEPNIPRVAR | 131 | Q5JT82 | |
| PMRPPGLVRNLQVTD | 841 | Q86VF2 | |
| ERGQVQMSDPRAPIP | 301 | Q9H0L4 | |
| IDPPAVPATGQFMRI | 1226 | Q7Z589 | |
| VSSKGQPSPRAVIPM | 66 | Q9HC35 | |
| GPSRSPQMGRRTPAQ | 341 | A6NIJ5 | |
| PQMGRRTPAQVPSVE | 346 | A6NIJ5 | |
| PQMGRRTPAQVPSVD | 346 | A8MXJ8 | |
| MAPTIVVPPGNRSVV | 291 | Q7Z5N4 | |
| MRQVNIVGTSPPSQP | 1071 | Q58EX2 | |
| MATALPPRLQPVRGN | 1 | Q99500 | |
| PAVNRTESPMGALQP | 376 | Q5FWE3 | |
| DRTAPSAGMQPQPSL | 406 | Q13555 | |
| RTLEIPGNSDPNMIP | 956 | P0C0L4 | |
| SGPPRQRPLSAAEMA | 31 | Q7Z4L0 | |
| PQMGRRTPAQVPSVD | 346 | P0C7X0 | |
| VPMAAAVPKAENPSR | 546 | Q9P2P1 | |
| PRQQARPSRGDSPIM | 1321 | Q9BZA8 | |
| GPPASIVPLMRQNRT | 576 | O96013 | |
| PLPPALGRQQAMAQS | 221 | Q5XKR4 | |
| MASLGANPRRTPQGP | 1 | O43196 | |
| GMETRPPANTARLQP | 346 | Q92918 | |
| DGSQRPPAVQLEPMA | 306 | Q2TAK8 | |
| PPLEALQSPSFRGNM | 101 | Q5T7P8 | |
| PKTAQSPAMVGSPIR | 286 | Q5VWG9 | |
| ERDMSNVSLGPTPIP | 301 | Q10713 | |
| RPLVPVLSPQSCGNM | 126 | Q9BSD3 | |
| TVISRPAGQENPKMP | 121 | Q6PI48 | |
| GSQPLLPSGMDPTRQ | 151 | P81877 | |
| NPRQPLPASGLATGM | 231 | Q96L08 | |
| TVAQSMPQSPRPGDR | 786 | Q7Z5M5 | |
| SQPMAPGVFLTQRRP | 1041 | O75151 | |
| VPQPTVPLGTCMRAN | 801 | B4DYI2 | |
| PDMPVRPGQLFSATL | 261 | Q24JP5 | |
| SQPSEAMAPRTGPAQ | 431 | O75157 | |
| SGNEPAENPVTPMLR | 31 | Q7L592 | |
| PQLGTKAPVARPRMS | 576 | Q9H4M7 | |
| KRQMPAAQDTPGAAP | 181 | O76081 | |
| PLFEVPGPNSRRANM | 806 | Q8IZX4 | |
| TINPGSTPMPRNIEG | 106 | Q14872 | |
| MFRNVPTANPTEPGI | 531 | Q9HDB5 | |
| PQMGRRTPAQVPSVD | 346 | A8MX19 | |
| PQMGRRTPAQVPSVD | 346 | A6NNJ1 | |
| PQMGRRTPAQVPSVD | 346 | P0C7W8 | |
| QLMGSINTIPAPSAP | 361 | A1L4K1 | |
| PPSSQAEGMGQVPRT | 2031 | O75376 | |
| MDAPRQVVNFGPGPA | 1 | Q9Y617 | |
| AQVGITMPRTKPSAP | 1066 | Q8IVL1 | |
| PGPVDMQSFRRPSAA | 461 | Q96QH2 | |
| EMQLQPLPSTSGPRA | 796 | Q9H0K1 | |
| PRTEAAAAPAGRAMP | 16 | Q9UNP4 | |
| GTQMSSVLPQPPLVR | 81 | Q8N8Z3 | |
| MVVVAAAPNPADGTP | 1 | P17861 | |
| SLMPVGDPPRTVLQA | 706 | Q9H6T0 | |
| AVPQPTVPLGTCMRA | 806 | P0DKV0 | |
| RIQASMAPAAALPPV | 76 | Q9UHV2 | |
| VRSPRPGSPQMQASP | 796 | E7EW31 | |
| QRVAPKPPQMSRAAD | 531 | Q13586 | |
| PMNPRPQESRTVFSG | 1596 | Q5VT25 | |
| PQMGRRTPAQVPSVD | 346 | P0C7V4 | |
| PRTMAAPQDSLRPGE | 596 | Q9BX79 | |
| GTPEMQAPVASRRKP | 476 | P25100 | |
| MNGDSRAAVVTSPPP | 1 | P35611 | |
| NRPNMEAVPLAPGRD | 256 | Q9H6R3 | |
| QPQLMLTAGPSVAVP | 1636 | Q00610 | |
| PNSGMQRAVQAPRPQ | 301 | Q8NA57 | |
| TAASPVPPMRPQAQG | 241 | Q96F05 | |
| APRILTNFTGVMPPQ | 2161 | A5YKK6 | |
| RPGVPTQAPINAQML | 1221 | Q15596 | |
| VMFNTEPPAGARAVP | 951 | Q96EP0 | |
| SPSLAPRMPFSIGQV | 456 | Q8ND24 | |
| PRPPRQGPTNEAQMA | 41 | Q9BZV1 | |
| SKRRIPVSQPGMADP | 21 | Q5BJH7 | |
| FSISGVQPARTPPML | 571 | Q9UKE5 | |
| PIPRSESCSQPVMNG | 581 | Q9H9J4 | |
| SMAVAAVSRPPVPVQ | 61 | A0PJW6 | |
| DPVSPAMVRSRNPGK | 241 | O94966 | |
| AGNVARPMVQRLPEP | 316 | P17643 | |
| MPANGTSPQRFPALI | 1 | P51786 | |
| PPRAAAFMGTPQNQT | 1251 | Q7Z2Z1 | |
| MSQPRTPEQALDTPG | 1 | Q9BSA9 | |
| NPEPRGANMSEPRLS | 246 | Q15697 | |
| ERQTRTRGPAPSAMP | 2181 | O15020 | |
| MAQQQALRFRGPAPP | 21 | O14776 | |
| DFQAPRNPTLTMGQP | 331 | Q8IZW8 | |
| PQELGPPVQRIQMTR | 2091 | P12270 | |
| VRVSPGQAAPAMARP | 716 | Q96HA7 | |
| MLPDTVAPQELNPRG | 36 | Q96GP6 | |
| PPRRSMPAVIGFQTA | 376 | Q6UWL2 | |
| PPLSVRPAVVMQGSA | 256 | P24928 | |
| VPVMGPSLASPSRAA | 286 | O95155 | |
| QPSSPGRAVPIKAMV | 256 | O00624 | |
| MAQSVLVPPGPDSFR | 1 | Q99250 | |
| QSLGKVAAARRMPPP | 46 | Q5JSZ5 | |
| DPVVPQGTAPLMFSR | 716 | A0A0J9YWL9 | |
| RAINPQGLSDPSPMS | 596 | Q9HCK4 | |
| NPPVTTNMHGVARPA | 1936 | Q68DE3 | |
| MAQASPPRPERVLGA | 1 | Q9UIL8 | |
| MPQRPAASNIPVVGS | 61 | Q5H9I0 | |
| PPTMTGDLQPRQVAS | 11 | Q96JG9 | |
| VRGPLQTASVSPSMP | 306 | Q8IWR0 | |
| QPSGIGQRPRPMSSE | 1171 | Q9H6S0 | |
| VMSVGPPAARLQEPV | 11 | P17098 | |
| TTPMAPGVFLTQRRP | 1006 | Q9UPP1 | |
| AQTVLRNPPAMSPAG | 266 | P21731 | |
| RRAQMTEGPNTAPPN | 1311 | Q9H4A3 | |
| PAAMFAPQVAARGVP | 256 | Q9NXA8 | |
| SFRQPPEMVPQQLGS | 346 | O15016 | |
| APAMVSALAQAPAPV | 396 | Q04206 | |
| RMGPLNISTPVEPVA | 371 | P40818 | |
| PVAIMASAQPAAIPS | 1501 | Q5VUA4 | |
| SQAQQPMDGPPVRIA | 221 | Q9H1B5 | |
| QNGAPRPMRFPRTVA | 166 | Q86SH2 | |
| QAAAPMATPTPRAEG | 76 | Q6UXF1 | |
| GPVLMRQSQPPSISF | 1176 | P82987 | |
| PQMGRRTPAQVPSVD | 346 | P0DV75 | |
| AVSPPVRDVGMNSPA | 2111 | Q5VU43 |